Spectranetics Corp. (SPNC)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
CEO:
Scott William Drake
Employees:
960
9965 FEDERAL DRIVE, COLORADO SPRINGS, CO 80921
7196338333

• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

The Spectranetics Corp. is a medical device company that develops, manufactures, markets and distributes single-use medical devices used in minimally invasive procedures within the cardiovascular system. Its products are used to treat arterial blockages in the heart and legs as well as the removal of pacemaker and defibrillator leads. It has two reportable segments, which were identified on a geographic basis: U.S.Medical and International Medical. These segments offer the same products and services but operate in different geographic regions, with different distribution networks and different regulatory environments. Within U.S. Medical, the company aggregates its two business units, Vascular Intervention and Lead Management. The Vascular Intervention business line manufactures and sells a range of peripheral and cardiac laser catheters for ablation of stenosed and occluded arteries above and below the knee and within coronary arteries. The Lead Management business line includes the manufacturing of excimer laser sheaths and cardiac lead management accessories, including lead locking stylets for manual traction and aid in laser-assisted extraction of cardiac pacemaker and defibrillator leads. The company was founded by Robert Golobic, Johan Sverdrup and Richard T. Simko in 1984 and is headquartered in Colorado Springs, CO.

Data derived from most recent annual or quarterly report
Market Cap 1.694 Billion Shares Outstanding44.046 Million Avg 30-day Volume 1.07 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-0.99
Price to Revenue5.9432 Debt to Equity2.7717 EBITDA-25.914 Million
Price to Book Value41.0603 Operating Margin-19.217100000000002 Enterprise Value1.748 Billion
Current Ratio1.917 EPS Growth-0.195 Quick Ratio1.415
1 Yr BETA 1.9304 52-week High/Low 0.0 / Profit Margin-24.2638
Operating Cash Flow Growth10.0817 Free Cash Flow to Firm (FCFF) TTM -31.342 Million Free Cash Flow to Equity (FCFE) TTM-14.811 Million
Altman Z-Score2.0634
View SEC Filings from SPNC instead.

View recent insider trading info

Spectranetics Corp. YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding SPNC (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding SPNC

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2017-08-11 by MCMAHAN STACY POWELL
  • 4: filed on 2017-08-11 by DRAKE SCOTT WILLIAM
  • 4: filed on 2017-08-11 by MATIN SHAHRIAR
  • 4: filed on 2017-08-11 by FORD-SERBU DONNA
  • 4: filed on 2017-08-11 by HUTTON SCOTT
  • 4: filed on 2017-08-11 by FLETCHER R JOHN
  • 4: filed on 2017-08-11 by JENNINGS WILLIAM C
  • 4: filed on 2017-08-11 by JOHNSON B KRISTINE
  • 4: filed on 2017-08-11 by PELAK DANIEL A
  • 4: filed on 2017-08-11 by RUGGIO JOSEPH M

    • Events (8k)

  • 8-K: filed on 2017-08-14:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2017-08-09:
    Item 1.02: Termination of a Material Definitive Agreement
    Item 2.01: Completion of Acquisition or Disposition of Assets
    Item 3.03: Material Modifications to Rights of Security Holders
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 9.01: Financial Statements and Exhibits
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
    Item 5.01: Changes in Control of Registrant
  • 8-K: filed on 2017-08-03:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2017-07-26:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2017-06-30:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2017-06-14:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2017-06-14:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2017-06-09:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2017-04-27:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2017-02-23:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    PELAK DANIEL A

    • Director
    		 No longer subject to file 2017-08-09 0

    SCHERMERHORN TODD C

    • Director
    		 No longer subject to file 2017-08-09 0

    FLETCHER R JOHN

    • Director
    		 No longer subject to file 2017-08-09 0

    JOHNSON B KRISTINE

    • Director
    		 No longer subject to file 2017-08-09 0

    RUGGIO JOSEPH M

    • Director
    		 No longer subject to file 2017-08-09 0

    JENNINGS WILLIAM C

    • Director
    		 No longer subject to file 2017-08-09 0

    MATIN SHAHRIAR CHIEF OPERATING OFFICER

    • Officer
    		 No longer subject to file 2017-08-09 0

    SAINZ MARIA

    • Director
    		 No longer subject to file 2017-08-09 0

    DRAKE SCOTT WILLIAM PRESIDENT, CEO

    • Officer
    • Director
    		 No longer subject to file 2017-08-09 0

    FORD-SERBU DONNA SR. VP SALES AND MKTG, LM

    • Officer
    		 No longer subject to file 2017-08-09 0

    MCMAHAN STACY POWELL CFO

    • Officer
    		 No longer subject to file 2017-08-09 0

    HUTTON SCOTT GENERAL MANAGER, VI

    • Officer
    		 No longer subject to file 2017-08-09 0

    SCHEINER UDO EDWIN SR. VP, INT'L OPERATIONS

    • Officer
    		 0 2016-03-31 0

    CHILDS GUY A

    • FORMER CFO
    		 No longer subject to file 2015-12-31 0

    BRIDGES KIMBERLY MCINTOSH SR VP, SALES & MKTG, VI

    • Officer
    		 4,431 2015-07-29 0

    BOWE WADE A VICE PRESIDENT R&D

    • Officer
    		 0 2015-06-11 0

    FUCHS ROBERT MICHAEL SR. VP, GLOBAL HUMAN RESOURCES

    • Officer
    		 0 2015-06-11 0

    BYRD AUSTIN BEVAN VP, CHIEF COMPLIANCE OFFICER

    • Officer
    		 0 2015-06-11 0

    GARDON PAUL SR. VP, GENERAL COUNSEL

    • Officer
    		 0 2015-06-11 0

    DOWLING ANNE MELISSA

    • Director
    		 36,788 2013-08-19 0

    HEIN JASON D SR. VP COMMERCIAL OPERATIONS

    • Officer
    		 0 2013-07-10 0

    WERTHEIMER ROGER VP, GENERAL COUNSEL, SECRETARY

    • Officer
    		 11,186 2013-06-01 0

    WALKER CRAIG W

    • Director
    		 448,353 2012-10-11 0

    BOEHME LISA RENEE VP & GM SALES, MKTG LEAD MGMT

    • Officer
    		 28,279 2012-05-31 0

    RIVAS FRANCISCO T. VP, CHIEF COMPLIANCE OFFICER

    • Officer
    		 0 2012-05-31 0

    FLETCHER DONALD C JR VP OF QUALITY SYSTEMS

    • Officer
    		 11,250 2012-04-16 0

    BLACKBURN DAVID G

    • Director
    		 35,884 2011-06-09 0

    RASMUSSEN THOMAS M VP OF CLINICAL AFFAIRS

    • Officer
    		 0 2011-04-15 0

    GEISENHEIMER EMILE J DIRECTOR

    • Officer
    • Director
    		 323,527 2011-02-03 0

    VAUGHAN JENNIFER VP SALES, VASC. INTERVENTION

    • Officer
    		 3,005 2010-03-01 0

    CAIN THOMPSON VP MKTG, VASC. INTERVENTION

    • Officer
    		 0 2009-01-26 0

    MCGUIRE JONATHAN WILL COO

    • Officer
    		 0 2008-12-08 0

    VOSS MICHAEL J VP & GM, VASCULAR INTERVENTION

    • Officer
    		 0 2008-12-08 0

    HANDLEY MICHAEL K VP GLOBAL REG. AFFAIRS & COMP

    • Officer
    		 480 2008-12-08 0

    SCHULTE JOHN G CEO

    • Officer
    • Director
    		 77,354 2008-08-28 0

    OKLAND STEPHEN D VICE PRESIDENT OF SALES

    • Officer
    		 0 2008-06-03 0

    HART MARTIN T

    • Director
    		 0 2006-02-08 0

    MARTEL LAWRENCE E JR VP OPERATIONS

    • Officer
    		 49,052 2006-01-10 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    WhaleWisdom Logo

    Elevate your investments